ORI
CRNX icon

Oak Ridge Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History

Oak Ridge Investments’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Buy
+37,548
New +$1.4M 0.08% 117

Other funds holding CRNX

MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
LAM
Lewis Asset Management Lafayette, California $285M AUM 32.52% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Oak Ridge Investments's CRNX Position: Q2 2026 in Review

Oak Ridge Investments opened a new position in Crinetics Pharmaceuticals (CRNX) in Q2 2026: 37,548 shares worth $1.41M. The stake represents 0.08% of the portfolio and ranks #117 among its holdings.

32 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Oak Ridge Investments held 37,548 shares of Crinetics Pharmaceuticals worth $1.41M as of Q2 2026.
  • Crinetics Pharmaceuticals was a new Oak Ridge Investments position in Q2 2026.
  • Crinetics Pharmaceuticals made up 0.08% of Oak Ridge Investments's portfolio in Q2 2026, its #117 holding.
  • 32 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.